• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Interleukin-1 receptor antagonist levels correlate with extent of myocardial loss in patients with acute myocardial infarction.白细胞介素-1受体拮抗剂水平与急性心肌梗死患者心肌梗死范围相关。
Clin Cardiol. 2005 Apr;28(4):193-6. doi: 10.1002/clc.4960280409.
2
Early interleukin-1 receptor antagonist elevation in patients with acute myocardial infarction.急性心肌梗死患者早期白细胞介素-1受体拮抗剂水平升高。
J Am Coll Cardiol. 2004 Jan 7;43(1):35-8. doi: 10.1016/j.jacc.2003.07.032.
3
Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.心脏生物标志物在预测ST段抬高型心肌梗死直接经皮冠状动脉介入治疗后的梗死面积、左心室功能及临床结局中的作用。
JACC Cardiovasc Interv. 2008 Aug;1(4):415-23. doi: 10.1016/j.jcin.2008.04.010.
4
Prognostic implications of an early peak in plasma MB creatine kinase in patients with acute myocardial infarction.急性心肌梗死患者血浆肌酸激酶同工酶早期峰值的预后意义
J Am Coll Cardiol. 1987 Nov;10(5):979-90. doi: 10.1016/s0735-1097(87)80334-0.
5
Delta creatine kinase-MB outperforms myoglobin at two hours during the emergency department identification and exclusion of troponin positive non-ST-segment elevation acute coronary syndromes.在急诊科对肌钙蛋白阳性的非ST段抬高型急性冠脉综合征进行识别和排除时,发病两小时内肌酸激酶同工酶的诊断价值优于肌红蛋白。
Ann Emerg Med. 2004 Jul;44(1):12-9. doi: 10.1016/j.annemergmed.2004.02.003.
6
Comparison of Troponin T to creatine kinase and to radionuclide cardiac imaging infarct size in patients with ST-elevation myocardial infarction undergoing primary angioplasty.对接受直接血管成形术的ST段抬高型心肌梗死患者,肌钙蛋白T与肌酸激酶及放射性核素心脏成像梗死面积的比较。
Am J Cardiol. 2008 Mar 15;101(6):753-7. doi: 10.1016/j.amjcard.2007.09.119. Epub 2008 Jan 14.
7
Relation between myocardial infarct size and ventricular tachyarrhythmia among patients with preserved left ventricular ejection fraction following fibrinolytic therapy for ST-segment elevation myocardial infarction.ST段抬高型心肌梗死溶栓治疗后左心室射血分数保留患者的心肌梗死面积与室性快速心律失常的关系
Am J Cardiol. 2009 Aug 15;104(4):475-9. doi: 10.1016/j.amjcard.2009.04.005. Epub 2009 Jun 17.
8
Prognostic importance of creatine kinase and creatine kinase-MB after primary percutaneous coronary intervention for ST-elevation myocardial infarction.ST段抬高型心肌梗死直接经皮冠状动脉介入治疗后肌酸激酶及肌酸激酶同工酶的预后意义
Am Heart J. 2008 Apr;155(4):673-9. doi: 10.1016/j.ahj.2007.11.004. Epub 2008 Feb 21.
9
Early peak creatine kinase activity is not always a marker of successful reperfusion with myocardial salvage in patients with reperfused anterior acute myocardial infarction.早期肌酸激酶活性峰值并不总是再灌注性前壁急性心肌梗死患者成功再灌注并伴有心肌挽救的标志。
Am Heart J. 2001 May;141(5):759-64. doi: 10.1067/mhj.2001.114370.
10
C-reactive protein in patients with acute coronary syndrome: correlation with diagnosis, myocardial damage, ejection fraction and angiographic findings.急性冠状动脉综合征患者的C反应蛋白:与诊断、心肌损伤、射血分数及血管造影结果的相关性
Int J Cardiol. 2006 May 10;109(2):248-56. doi: 10.1016/j.ijcard.2005.06.021. Epub 2005 Aug 1.

引用本文的文献

1
IL-6, IL-1RA and Resistin as Predictors of Left Ventricular Remodelling and Major Adverse Cardiac Events in Patients with Acute ST Elevation Myocardial Infarction.白细胞介素-6、白细胞介素-1受体拮抗剂和抵抗素作为急性ST段抬高型心肌梗死患者左心室重构及主要不良心脏事件的预测指标
Diagnostics (Basel). 2022 Jan 21;12(2):266. doi: 10.3390/diagnostics12020266.
2
Role of NLRP3 Inflammasome in Myocardial Ischemia-Reperfusion Injury and Ventricular Remodeling.NLRP3 炎性小体在心肌缺血再灌注损伤及心室重构中的作用。
Med Sci Monit. 2022 Jan 19;28:e934255. doi: 10.12659/MSM.934255.
3
Imbalance Between Interleukin-1β and Interleukin-1 Receptor Antagonist in Epicardial Adipose Tissue Is Associated With Non ST-Segment Elevation Acute Coronary Syndrome.心外膜脂肪组织中白细胞介素-1β与白细胞介素-1受体拮抗剂之间的失衡与非ST段抬高型急性冠状动脉综合征相关。
Front Physiol. 2020 Feb 5;11:42. doi: 10.3389/fphys.2020.00042. eCollection 2020.
4
Examining the Role of and Treatment Directed at IL-1β in Atherosclerosis.探讨白细胞介素-1β在动脉粥样硬化中的作用及治疗方法。
Curr Atheroscler Rep. 2018 Sep 15;20(11):53. doi: 10.1007/s11883-018-0754-6.
5
Temporal changes in biomarkers and their relationships to reperfusion and to clinical outcomes among patients with ST segment elevation myocardial infarction.ST段抬高型心肌梗死患者生物标志物的时间变化及其与再灌注和临床结局的关系。
J Thromb Thrombolysis. 2016 Oct;42(3):376-85. doi: 10.1007/s11239-016-1390-z.
6
Bone Marrow Mononuclear Cell Transplantation Restores Inflammatory Balance of Cytokines after ST Segment Elevation Myocardial Infarction.骨髓单个核细胞移植可恢复ST段抬高型心肌梗死后细胞因子的炎症平衡。
PLoS One. 2015 Dec 21;10(12):e0145094. doi: 10.1371/journal.pone.0145094. eCollection 2015.
7
Interleukin-1 in cardiac injury, repair, and remodeling: pathophysiologic and translational concepts.白细胞介素-1在心脏损伤、修复及重塑中的作用:病理生理及转化医学概念
Discoveries (Craiova). 2015 Jan-Mar;3(1). doi: 10.15190/d.2015.33.
8
Emerging families of biomarkers for coronary artery disease: inflammatory mediators.冠心病生物标志物的新兴类别:炎症介质
Vasc Health Risk Manag. 2013;9:435-56. doi: 10.2147/VHRM.S45704. Epub 2013 Jul 31.
9
Impact of an interleukin-1 receptor antagonist and erythropoietin on experimental myocardial ischemia/reperfusion injury.白细胞介素-1受体拮抗剂和促红细胞生成素对实验性心肌缺血/再灌注损伤的影响
ScientificWorldJournal. 2012;2012:737585. doi: 10.1100/2012/737585. Epub 2012 May 2.
10
The role of IL-1 in the pathogenesis of heart disease.白细胞介素-1在心脏病发病机制中的作用。
Arch Immunol Ther Exp (Warsz). 2009 May-Jun;57(3):165-76. doi: 10.1007/s00005-009-0024-y. Epub 2009 May 29.

本文引用的文献

1
Early interleukin-1 receptor antagonist elevation in patients with acute myocardial infarction.急性心肌梗死患者早期白细胞介素-1受体拮抗剂水平升高。
J Am Coll Cardiol. 2004 Jan 7;43(1):35-8. doi: 10.1016/j.jacc.2003.07.032.
2
Interleukin-1 receptor antagonist: a sensitive marker of instability in patients with coronary artery disease.白细胞介素-1受体拮抗剂:冠心病患者病情不稳定的敏感标志物。
J Thromb Thrombolysis. 2002 Oct;14(2):139-43. doi: 10.1023/a:1023284912712.
3
Differential cytokine expression in myocytes and non-myocytes after myocardial infarction in rats.大鼠心肌梗死后心肌细胞与非心肌细胞中细胞因子的差异表达
Mol Cell Biochem. 2003 Jan;242(1-2):47-55.
4
Inflammatory markers and coronary interventions: a potentially useful follow-up modality after stenting.
Catheter Cardiovasc Interv. 2002 Jul;56(3):341-5. doi: 10.1002/ccd.10201.
5
Prognostic value of interleukin-1 receptor antagonist in patients undergoing percutaneous coronary intervention.白细胞介素-1受体拮抗剂在接受经皮冠状动脉介入治疗患者中的预后价值
Am J Cardiol. 2002 Feb 15;89(4):372-6. doi: 10.1016/s0002-9149(01)02254-8.
6
Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1beta.抑制半胱天冬酶-1可通过抑制白细胞介素-18和白细胞介素-1β减轻人类心肌缺血性功能障碍。
Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2871-6. doi: 10.1073/pnas.041611398.
7
Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events.不稳定型心绞痛患者住院后前两天白细胞介素(IL)-1Ra和IL-6水平升高与院内冠状动脉事件风险增加相关。
Circulation. 1999 Apr 27;99(16):2079-84. doi: 10.1161/01.cir.99.16.2079.
8
The interleukin-1 and interleukin-1 converting enzyme families in the cardiovascular system.心血管系统中的白细胞介素-1和白细胞介素-1转化酶家族。
Eur Cytokine Netw. 1998 Dec;9(4):675-80.
9
Atherosclerosis--an inflammatory disease.动脉粥样硬化——一种炎症性疾病。
N Engl J Med. 1999 Jan 14;340(2):115-26. doi: 10.1056/NEJM199901143400207.
10
Elevated plasma levels of interleukin-1 receptor antagonist and interleukin-10 in patients with acute myocardial infarction.
J Interferon Cytokine Res. 1997 Mar;17(3):145-50. doi: 10.1089/jir.1997.17.145.

白细胞介素-1受体拮抗剂水平与急性心肌梗死患者心肌梗死范围相关。

Interleukin-1 receptor antagonist levels correlate with extent of myocardial loss in patients with acute myocardial infarction.

作者信息

Patti Giuseppe, Mega Simona, Pasceri Vincenzo, Nusca Annunziata, Giorgi Gabriele, Zardi Enrico Maria, D'Ambrosio Andrea, Dobrina Aldo, Di Sciascio Germano

机构信息

Department of Cardiovascular Sciences, Campus Bio-Medico University, Rome, Italy.

出版信息

Clin Cardiol. 2005 Apr;28(4):193-6. doi: 10.1002/clc.4960280409.

DOI:10.1002/clc.4960280409
PMID:15869054
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6654761/
Abstract

BACKGROUND

Interleukin-1 receptor antagonist (IL-1Ra) levels are elevated early in patients with acute myocardial infarction (MI) and often precede release of markers of necrosis; however, IL-1Ra levels did not correlate previously with infarct size and prognosis in such patients.

HYPOTHESIS

The goal of our study was to evaluate prospectively the correlation between IL-1Ra levels upon emergency department (ED) presentation and the extent of myocardial necrosis and prognosis in patients with ST-segment elevation MI.

METHODS

Levels of IL-1Ra were measured upon ED presentation in 44 consecutive patients (40 men, aged 55 +/- 10 years). Peak values of creatine kinase (CK) and CK-MB were determined during hospitalization, and left ventricular ejection fraction (LVEF) was evaluated by echocardiography before discharge. All patients were followed prospectively and underwent clinical and echocardiographic assessment at 42 +/- 3 months after the infarction.

RESULTS

Levels of IL-1Ra upon ED presentation correlated directly with CK (p = 0.002) and CK-MB (p = 0.01) peak levels and correlated inversely with LVEF before discharge (p = 0.009). Patients with in-hospital adverse events had significantly higher IL-1Ra levels upon ED admission (n = 10,2620 +/- 4706 pg/ml) than those without events (n = 34,598 +/- 457 pg/ml) (p = 0.015).

CONCLUSIONS

In patients with MI, levels of IL-1Ra upon ED presentation correlated significantly with the extent of myocardial necrosis, as measured by cardiac enzymes peak and reduction of LVEF, and are predictive of in-hospital events. Results of this study may influence early therapeutic approach in patients with acute MI.

摘要

背景

急性心肌梗死(MI)患者早期白细胞介素-1受体拮抗剂(IL-1Ra)水平升高,且常先于坏死标志物的释放;然而,此前此类患者的IL-1Ra水平与梗死面积及预后并无关联。

假说

我们研究的目的是前瞻性评估急诊科(ED)就诊时IL-1Ra水平与ST段抬高型心肌梗死患者心肌坏死程度及预后之间的相关性。

方法

对44例连续患者(40例男性,年龄55±10岁)在ED就诊时测定IL-1Ra水平。住院期间测定肌酸激酶(CK)和CK-MB的峰值,出院前通过超声心动图评估左心室射血分数(LVEF)。对所有患者进行前瞻性随访,并在心肌梗死后42±3个月进行临床和超声心动图评估。

结果

ED就诊时IL-1Ra水平与CK(p = 0.002)和CK-MB(p = 0.01)的峰值水平呈正相关,与出院前LVEF呈负相关(p = 0.009)。住院期间发生不良事件的患者在ED入院时的IL-1Ra水平(n = 10,2620±4706 pg/ml)显著高于未发生事件的患者(n = 34,598±457 pg/ml)(p = 0.015)。

结论

在心肌梗死患者中,ED就诊时IL-1Ra水平与心肌坏死程度显著相关,心肌坏死程度通过心肌酶峰值和LVEF降低来衡量,且可预测住院期间的事件。本研究结果可能会影响急性心肌梗死患者的早期治疗方法。